M. R. Moore

1.4k total citations
41 papers, 1.1k citations indexed

About

M. R. Moore is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, M. R. Moore has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in M. R. Moore's work include Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (5 papers) and Lung Cancer Treatments and Mutations (4 papers). M. R. Moore is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (5 papers) and Lung Cancer Treatments and Mutations (4 papers). M. R. Moore collaborates with scholars based in United States, United Kingdom and Puerto Rico. M. R. Moore's co-authors include Graydon Harker, Charles S. Fuchs, David Rinaldi, Luis Villa, J. Randolph Hecht, Saul A. Rosenberg, Stephen E. Jones, Joan M. Bull, Sarah S. Donaldson and Norman Blank and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

M. R. Moore

38 papers receiving 1.1k citations

Peers

Countries citing papers authored by M. R. Moore

Since Specialization

Citations

This map shows the geographic impact of M. R. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. R. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. R. Moore more than expected).

Fields of papers citing papers by M. R. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. R. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. R. Moore. The network helps show where M. R. Moore may publish in the future.

Co-authorship network of co-authors of M. R. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of M. R. Moore. A scholar is included among the top collaborators of M. R. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. R. Moore. M. R. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of Ultraviolet Water Treatment on Survival and Growth of Escherichia coli in Recirculating Hydroponic Systems 2025 ·Journal of Food Protection ·M. R. Moore, Teng Yang, (unknown), Cary L. Rivard, (unknown), (unknown), Manreet Bhullar	0
2	Abstract 4147550: Evaluating the Clinical Reasoning of GPT-4, Grok, and Gemini in Different Fields of Cardiology 2024 ·Circulation ·(unknown), (unknown), (unknown), Sajid Ali, CHARLES L. GIBSON, Jorge Saucedo, Matías Calandrelli, (unknown), (unknown), Gerald Chi, (unknown), M. R. Moore, (unknown), (unknown), Antonio Gordillo‐Moscoso, (unknown)	1
3	Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer 2022 ·Urologic Oncology Seminars and Original Investigations ·(unknown), Katherine E. Smith, (unknown), Jacqueline T. Brown, (unknown), (unknown), Sarah Caulfield, (unknown), M. R. Moore, Ömer Küçük, Bradley Curtis Carthon, Bassel Nazha, Yuan Liu, Mehmet Asım Bilen	13
4	Syndecan-1 facilitates breast cancer metastasis to the brain 2019 ·Breast Cancer Research and Treatment ·(unknown), Madhavi Puchalapalli, (unknown), (unknown), M. R. Moore, (unknown), (unknown), (unknown), (unknown), Megan Sullivan, Mikhail G. Dozmorov, (unknown), Michael O. Idowu, Jennifer E. Koblinski	63
5	Discordance in Monogamy Beliefs, Sexual Concurrency, and Condom Use Among Young Adult Substance-Involved Couples: Implications for Risk of Sexually Transmitted Infections 2006 ·Sexually Transmitted Diseases ·Kara Riehman, Wendee M. Wechsberg, Shelley A. Francis, M. R. Moore, Antonio A. Morgan‐López	35
6	Phase II trial of DJ-927, an oral tubulin depolymerization inhibitor, in the treatment of metastatic colorectal cancer 2006 ·Journal of Clinical Oncology ·M. R. Moore, (unknown), Graydon Harker, (unknown), Bach Ardalan, Muhammad Wasif Saif, Paul Hoff, (unknown), (unknown), Kristen D. Felt	11
7	Dioxin-like chemicals in bivalves and sediment collected from around Australia 2004 ·Nephron ·John A. Mueller, Regina Céli Sarkis Müller, (unknown), Melanie Shaw, Munro Mortimer, David Haynes, (unknown), Ross V. Hyne, Debbie Burniston, Robert Symons, M. R. Moore	1
8	The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer 2004 ·Seminars in Oncology ·Nicholas J. Robert, Charles L. Vogel, I. Craig Henderson, Joseph A. Sparano, M. R. Moore, Paula Silverman, Beth Overmoyer, Charles L. Shapiro, John W. Park, Gail Colbern, Eric P. Winer, Alberto Gabizón	60
9	Human Health Risk Assessment 2004 ·Queensland's institutional digital repository (The University of Queensland) ·Brian G. Priestly, M. R. Moore, B. N. Noller, J. C. Ng	1
10	Expandable Tubular Casing Repairs: Four Case Histories 2003 ·Proceedings of SPE Annual Technical Conference and Exhibition ·Jonathan P. Wright, M. R. Moore, (unknown)	2
11	PCDD/FS in a historic butter sample from Australia 2002 ·Queensland's institutional digital repository (The University of Queensland) ·Jochen F. Mueller, Joelle Prange, Caroline Gaus, (unknown), (unknown), M. R. Moore, Olaf Päpke, (unknown)	2
12	A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma 2001 ·Cancer ·William J. Gradishar, Patricia Stephenson, Donna Glover, Donna Neuberg, M. R. Moore, Harold E. Windschitl, (unknown), Martin D. Abeloff	17
13	The Use of Controlled-Release Oxycodone for the Treatment of Chronic Cancer Pain 1998 ·Journal of Pain and Symptom Management ·Winston C. V. Parris, Benjamin Johnson, (unknown), M. R. Moore, Ali Khojasteh, Robert F. Reder, Robert F. Kaiko, Barbara J. Buckley	36
14	Conservative treatment of early-stage breast cancer in a medically indigent population. 1995 ·PubMed Central ·(unknown), Jerome C. Landry, Lorie L. Hughes, M. R. Moore, M. J. Lynn, L. W. Davis, Toncred M. Styblo, Ian Crocker, W. C. Wood	10
15	A survey of alcohol use in an inner-city ambulatory care setting 1991 ·Journal of General Internal Medicine ·(unknown), J. William Eley, Raymond S. Greenberg, Nancy Newman, Theresa Gillespie, M. R. Moore	14
16	Reproducibility of Food Frequency Measurements and Inferences from a Case-Control Study 1990 ·Epidemiology ·Alfredo Morabia, M. R. Moore, E. L. Wynder	23
17	Compartment Syndrome of the Thigh Complicating Surgical Treatment of Ipsilateral Femur and Ankle Fractures 1987 ·Journal of Orthopaedic Trauma ·M. R. Moore, S R Garfin, Alan R. Hargens	15
18	Phase II evaluation of cisplatin in squamous carcinoma of the esophagus: a Southeastern Cancer Study Group trial. 1985 ·PubMed ·(unknown), M. R. Moore, G A Omura, (unknown), A Bartolucci	10
19	Postmastectomy adjuvant chemotherapy with or without radiation therapy in women with operable breast cancer and positive axillary lymph nodes: The Southeastern Cancer Study Group experience 1983 ·Breast Cancer Research and Treatment ·(unknown), M. R. Moore, Charles L. Vogel, Víctor A. Marcial, Alfred S. Ketcham, Alfred A. Bartolucci, (unknown), Richard V. Smalley	12
20	Characterization of Postsplenectomy Bacteremia among Patients with and without Lymphoma 1972 ·New England Journal of Medicine ·Sarah S. Donaldson, M. R. Moore, Saul A. Rosenberg, Kenneth L. Vosti	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact